The total protein expression of RCC2 was considerably elevated in pancreatic adenocarcinoma (PAAD), COAD, ovarian serous cystadenocarcinoma (OV), GBM and BRCA tumors compared to normal tissues (Figure 1B). Here, RCC2 is linked to colon adenocarcinoma.